Guggenheim Capital’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-693
| Closed | -$1.97M | – | 2670 |
|
|
2018
Q1 | $1.97M | Sell |
693
-75
| -10% | -$213K | ﹤0.01% | 1652 |
|
|
2017
Q4 | $1.98M | Sell |
768
-208
| -21% | -$535K | ﹤0.01% | 1677 |
|
|
2017
Q3 | $2.77M | Buy |
976
+108
| +12% | +$306K | 0.01% | 1434 |
|
|
2017
Q2 | $2.05M | Buy |
868
+162
| +23% | +$383K | 0.01% | 1603 |
|
|
2017
Q1 | $1.78M | Sell |
706
-53
| -7% | -$134K | ﹤0.01% | 1751 |
|
|
2016
Q4 | $1.71M | Sell |
759
-195
| -20% | -$440K | ﹤0.01% | 1800 |
|
|
2016
Q3 | $2.39M | Sell |
954
-44
| -4% | -$110K | 0.01% | 1502 |
|
|
2016
Q2 | $3.06M | Sell |
998
-44
| -4% | -$135K | 0.01% | 1287 |
|
|
2016
Q1 | $3.31M | Sell |
1,042
-148
| -12% | -$470K | 0.01% | 1234 |
|
|
2015
Q4 | $6.11M | Sell |
1,190
-413
| -26% | -$2.12M | 0.02% | 931 |
|
|
2015
Q3 | $5.1M | Sell |
1,603
-64
| -4% | -$204K | 0.02% | 1024 |
|
|
2015
Q2 | $6.67M | Buy |
1,667
+184
| +12% | +$736K | 0.02% | 1020 |
|
|
2015
Q1 | $5.92M | Buy |
1,483
+536
| +57% | +$2.14M | 0.01% | 1079 |
|
|
2014
Q4 | $4.64M | Sell |
947
-249
| -21% | -$1.22M | 0.01% | 1161 |
|
|
2014
Q3 | $4.86M | Buy |
1,196
+124
| +12% | +$504K | 0.01% | 1196 |
|
|
2014
Q2 | $4.34M | Sell |
1,072
-167
| -13% | -$676K | 0.01% | 1245 |
|
|
2014
Q1 | $5.64M | Sell |
1,239
-173
| -12% | -$787K | 0.02% | 1054 |
|
|
2013
Q4 | $4.95M | Buy |
1,412
+259
| +22% | +$908K | 0.02% | 1090 |
|
|
2013
Q3 | $4.75M | Buy |
1,153
+237
| +26% | +$975K | 0.02% | 1112 |
|
|
2013
Q2 | $3.63M | Buy |
+916
| New | +$3.63M | 0.02% | 1197 |
|